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Abstract Centenarians represent a rapidly growing
population. To better characterize this specific age
group, we have performed a cross-sectional study to
observe associations between functional measures and
a range of biochemical markers, including inflammatory
markers and their significance as predictors of 360-day
survival. Medical history and physical and functional
assessment (Mini-Mental State Examination (MMSE),
Katz Index (activities of daily living, ADL) and Barthel
Index (Barthel Index) of Activities of Daily Living, and
Lawton Instrumental Activities of Daily Living Scale
(Lawton IADL)) were conducted on 86 101.9 ± 1.2-
year-old (mean ± SD) subjects (70 women, 16 men).
Blood tests were performed on 84 subjects of whom 43
also had extended biomarker assessment. As a reference
group 30 51.8 ± 5.0-year old healthy subjects (20 wom-
en, 10 men) were recruited. The centenarians received
follow-up phone calls. Fifty-two centenarians (60 %)
survived ≥360 days. Longer survival was associated
with higher MMSE (hazard ratio, HR = 0.934, 95 %
confidence interval (CI) 0.896–0.975, P = .002), ADL
(HR = 0.840, 95 % CI 0.716–0.985, P = .032), Barthel
Index (HR = 0.988, 95 % CI 0.977–0.999, P = .026),
and albumin level (HR .926, 95 % CI 0.870–0.986, P
.016) and with lower white blood cell (WBC)
(HR = 1.161, 95 % CI 1.059–1.273, P = .001), C-
reactive protein (CRP) (HR = 1.032, 95 % CI 1.014–
1.050, P < .001), IL-6 (HR = 1.182, 95 % CI 1.047–
1.335, P = .007), and endothelin-1 (ET-1) level
(HR = 3.711, 95 % CI 1.233–11.169, P = .020). Cente-
narians had higher 360-day survival probability with
MMSE ≥13 (P < .001), ADL ≥1 (P < .001), Barthel
Index ≥15 (P < .001), Lawton IADL ≥10 points
(P = .009), WBC <8.3 G/L (P = .039), CRP <10 mg/L
(P < .001), IL-6 <6 pg/mL (P .002), and ET-1 <1.1 pg/
mL (P .007). Our results indicate that functional mea-
sures, inflammatory markers, and endothelin-1 are pre-
dictors of 360-day survival in centenarians.
Keywords Centenarians . Mini-Mental State
Examination . Activities of daily living . 360-day
survival . Interleukin-6 . Endothelin-1
Background
Survival over 100 years of age used to be an extraordi-
nary occurrence. However, over the past several de-
cades, the world population of the oldest old is growing
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rapidly. According to the Central Statistical Office of
Poland, the number of centenarians per 100,000 people
will increase from 1 in 1970 to 9 in 2010 and to a
projected 174 in the year 2050 (Central Statistical Office
of Poland 2014). Clinical studies concerning centenar-
ians are critical for equipping policy makers, social care
providers, and clinicians with appropriate knowledge
regarding the health and social needs of this unique
age group. There is increasing evidence that would
suggest changes in the meaning of health indicators as
human life progresses, making centenarians distinctive
even of younger seniors. A pervasive feature of aging is
low-grade, chronic , sys temic inf lammat ion
(inflammaging) revealed by elevated levels of inflam-
matory biomarkers such as C-reactive protein, interleu-
kin-6, and tumor necrosis factor alpha (Maes et al. 1999;
Franceschi et al. 2000; Bruunsgaard et al. 2003;
Michaud et al. 2013). This state of mild inflammation
is predictive of numerous aging phenotypes and repre-
sents a highly significant risk factor for both morbidity
and mortality among the elderly (Franceschi et al. 2000;
Franceschi and Campisi 2014). Inflammation is strongly
associated with incident cardiovascular events (Cesari
et al. 2003) showing a close relationship between in-
flammation and vascular aging (Sun 2015). It has also
been shown that inflammation is a key predictor of
health status in the elderly (Barodka et al. 2011).
Inflammaging may also be involved in the pathophysi-
ology of neurodegenerative disorders and cognitive im-
pairment (e.g. Alzheimer disease) (Tan et al. 2007;
Michaud et al. 2013; Cunningham and Hennessy
2015). As is the case with unsuccessful aging, centenar-
ians are also affected by systemic inflammation as well
as other signs of age-related homeostasis disorders, e.g.,
decreased antioxidant levels and hypercoagulable states
(Franceschi and Campisi 2014). However, as opposed to
those who age poorly, centenarians survive or delay the
onset of chronic age-related disease such as type 2
diabetes, cardiovascular disease, severe dementia, and
cancer. Centenarians have even been shown to Bescape^
chronic disease (Evert et al. 2003; Arnold et al. 2010;
Sebastiani et al. 2013), which has come to be considered
Bthe paradox of centenarians^ (Franceschi and Campisi
2014). Despite being afflicted with clinically evident
morbidities, there is evidence that centenarians appear
to compress their disability toward the end of their lives
(Terry et al. 2008). Andersen et al. (2012) observed a
progressive delay in the age of onset of physical and
cognitive function impairment, age-related diseases, and
overall morbidity with increasing age. As the limit of the
human life span was effectively approached with
supercentenarians, compression of morbidity was gen-
erally observed. Healthy centenarians constitute a sub-
population of elderly that is characterized both by in-
creased longevity and maintenance of functional inde-
pendence (Franceschi and Bonafè 2003). Therefore,
centenarian studies contribute substantially to under-
standing the aging process and the factors influencing
longevity (Willcox et al. 2010). Relationships between
inflammaging, vascular aging, functional status, and
longevity have not been extensively explored for cente-
narians. We completed a cross-sectional study to char-
acterize the health state of centenarians in Upper Silesia,
the most industrialized region of Poland. To assess
mental and physical performance, we used measures
of cognitive function and independence in basic and
instrumental activities of daily living used in compre-
hensive geriatric assessment. Among widely accepted
inflammatory markers, in order to assess the inflamma-
tory status of our study group, we analyzed the blood
work for factors assessing immune system activation,
extracellular matrix turnover, and vascular injury. We
chose interleukin-6 (IL-6), tumor necrosis factor alpha
(TNF-α), C-reactive protein (CRP), and CD40 ligand
(CD40L) as widely accepted inflammatory markers.
Activation of the immune system was assessed by ex-
amining levels of integrins intercellular adhesion
molecule-1 (ICAM-1), vascular cell adhesion
molecule-1 (VCAM-1), and P-selectin, which are in-
duced by proinflammatory cytokines IL-6 and TNF-α
and are responsible for inflammatory cell adhesion and
penetration of the vascular wall. Extracellular matrix
turnover was assessed by examining levels of metallo-
proteinases 1 and 9 and tissue inhibitor of metallopro-
teinases 1 (Thakore et al. 2007; Zakynthinos and Pappa
2009). To understand the vascular function of our study
population, we assessed endothelin-1, a potent vasocon-
strictor, and plasminogen activator inhibitor 1, an im-
portant risk factor for thrombosis and atherosclerosis
(Paulus et al. 2011). Our results were presented partially
in our preliminary papers, where we focused on the
relationship between blood pressure, mental and physi-
cal performance, and 180-day survival in the study
group (Szewieczek et al. 2011, 2015). In this paper, we
present an analysis of associations between functional
measures and a range of biochemical markers, including
inflammatory markers, to assess their significance as
predictors of 360-day survival.
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Methods
Participants
Our study was conducted from January 2007 to August
2013 and included 86 consecutive subjects (70 women
and 16 men) aged 100.9 ± 1.2 years (mean ± SD) in the
range 99.1 to 104.7 years who responded positively to
invitation letters (8 % of addressees). A residential visit
by the team consisting of a physician and two nurses
was scheduled with the subject and their caregiver.
Selected biochemical markers were also determined in
a control group of 30 healthy subjects (20 women and
10 men) aged 51.8 ± 5.0 years.
Measurements
The assessment included a structured interview, physi-
cal examination, functional measures (Katz ADL,
Barthel Index, Lawton IADL, and MMSE), and blood
sampling. The Mini-Mental State Examination
(MMSE) (Folstein et al. 1975) was used to assess global
cognitive performance. The Katz Index of Indepen-
dence in Activities of Daily Living (Katz ADL) (Katz
et al. 1963), Barthel Index of Activities of Daily Living
(Barthel Index) (Mahoney and Barthel 1965), and Law-
ton Instrumental Activities of Daily Living Scale (Law-
ton IADL) (Lawton and Brody 1969) were used to
determine functional status. MMSE scores range from
0 to 30, Katz ADL scores from 0 to 6, Barthel Index
scores from 0 to 100, and Lawton IADL scores
from 9 to 27; higher scores indicate better func-
tional state.
Laboratory tests performed for 84 centenarians (two
subjects refused consent for blood sampling) are listed
in Table 1. All biochemical markers were assessed in
fasting blood samples.
In the course of the study, we extended the scope of
assessed biomarkers for commonly used markers of
endothelial dysfunction and vascular health. Thus, plas-
ma levels of soluble P-selectin (sP-selectin), soluble
intercellular adhesion molecule-1 (sICAM-1), soluble
vascular cell adhesion molecule-1 (sVCAM-1), soluble
CD40 ligand (sCD40L), interleukin-6 (IL-6),
endothelin-1 (ET-1), TNF-α, plasminogen activator
inhibitor-1 (PAI-1), matrix metalloproteinase-1 (MMP-
1), matrix metalloproteinase-9 (MMP-9), and a tissue
inhibitor of metalloproteinase (TIMP-1) were deter-
mined for 43 centenarians (28 survivors and 15 non-
survivors) and 30 quinquagenarian healthy controls as a
reference group. Commercially available ELISA kits
(R&D Systems, Minneapolis, MN, USA) were used.
Briefly, 5 mL EDTA-blood was centrifuged for 10 min
at 1000 rpm; the obtained plasma was frozen in 1 mL
aliquots at −80 °C until analysis. Just prior to sICAM-1,
sVCAM-1, and sP-selectin determinations, samples
were diluted 200 times so that they would remain within
the dynamic range of the assay. sCD40L was deter-
mined in undiluted plasma samples. IL-6 and TNF-α
were assessed using a high-sensitivity assay due to
extremely low concentrations of the above molecules
in human serum. The detection limit for IL-6 was
0.039 pg/mL, and for TNF-α was 0.106 pg/mL. ET-1
was detected using a chemiluminescent assay; the min-
imum detectable concentration was 0.064 pg/mL. A kit
used for the assessment had about 50 % cross-reactivity
with ET-2 and virtually no cross-reactivity with ET-3,
big-ET-2/3, or other forms of endothelins. Absorbance
and luminescence were read using Tecan Infinite M200
Pro Plate Reader (Tecan Group, Switzerland). Biomark-
er samples were reassayed at least twice and the mean
value was used for analysis. The study subjects received
follow-up phone calls for at least 360 days.
Statistical Analysis
Data were analyzed using STATISTICA software ver-
sion 10 (StatSoft, Inc., USA; StatSoft Poland). The Cox
proportional hazards regression model was used for
survival analysis. Nonparametric Mann–Whitney U test
(for quantitative variables), chi-square test, V-square
test, and Fisher’s exact test (for categorical variables)
were used to compare centenarians who survived
360 days with those who did not survive. The Mann–
Whitney U test was also used to compare selected
biochemical markers (cytokines) among the groups of
centenarians and healthy quinquagenarians. The Cox
proportional hazards model was used for univariate
and multivariate survival analysis. The Kaplan–Meier
method was used to estimate survival probability in
subgroups of centenarians with respect to selected var-
iables, while differences between these subgroups were
assessed with the Wilcoxon–Gehan statistic. Variables
were tested to define the value corresponding with the
lowest P level. The nonparametric Spearman’s rank
correlation coefficient was used to assess relationships
between blood pressure, functional measures, and
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Mean ± SD or percentage P value
Age, years 100.81 ± 0.99 101.09 ± 0.40 .581
Hypertension, % 94.2 76.5 .038
Diabetes mellitus, % 19.2 17.6 .854
Myocardial infarction in anamnesis, % 5.77 11.76 .555
Stroke in anamnesis, % 17.3 25.9 .704
Chronic obstructive pulmonary disease, % 13.5 14.7 .871
Chronic renal failure, % 19.0 17.6 .782
Cancer in anamnesis, % 3.85 9.68 .622
Ever smoking, % 8.33 25.9 .156
Number of used medications 4.83 ± 3.07 4.91 ± 3.18 .905
Body mass index, kg/m2 23.7 ± 4.9 23.7 ± 3.7 .940
Heart rate, beats per minute 73.6 ± 12.4 75.3 ± 12.2 .450
Systolic blood pressure, mmHg 153.4 ± 3.1 144.6 ± 24.8 .188
Diastolic blood pressure, mmHg 78.1 ± 16.5 76.2 ± 11.4 .436
Mean arterial pressure, mmHg 103.2 ± 18.3 99.0 ± 13.2 .310
Pulse pressure, mmHg 74.8 ± 26.3 68.1 ± 23.4 .389
MMSE score 17.9 ± 7.2 13.5 ± 8.7 .013
Katz ADL 3.52 ± 2.03 2.74 ± 2.30 .083
Barthel Index 62.6 ± 28.5 50.7 ± 35.9 .149
Lawton IADL 12.0 ± 3.6 11.2 ± 4.8 .069
Hemoglobin, mmol/L 7.89 ± 0.90 7.76 ± 0.81 .454
Red blood cells, T/L 4.29 ± 0.51 4.22 ± 0.52 .516
White blood cells, G/L 6.19 ± 2.06 7.95 ± 6.79 .063
Thrombocytes, G/L 227 ± 77 215 ± 86 .510
Bilirubin, μmol/L 12.1 ± 5.0 13.1 ± 8.6 .912
ALAT, nmol/L/s 366 ± 1057 202 ± 109 .349
Albumin, g/L 38.6 ± 5.4 35.9 ± 5.3 .033
Creatinine, μmol/L 96.5 ± 24.0 129.7 ± 166.5 .668
Cystatin C, mg/mL 1.72 ± 0.81 1.78 ± 0.79 .865
Glucose, mmol/L 5.32 ± 1.20 5.28 ± 0.87 .818
Insulin, pmol/L 62.2 ± 35.6 62.5 ± 4.9 .951
Thyrotropin, mIU/L 1.89 ± 1.39 1.89 ± 2.15 .552
Folate, nmol/L 13.6 ± 8.7 16.2 ± 1.2 .281
Vitamin B12, pmol/L 307 ± 242 249 ± 141 .463
Total cholesterol, mmol/L 5.13 ± 1.24 4.77 ± 1.26 .100
HDL cholesterol, mmol/L 1.65 ± 0.52 1.51 ± 0.58 .224
LDL cholesterol, mmol/L 2.96 ± 0.98 2.76 ± 1.12 .177
Triglycerides, mmol/L 1.17 ± 0.50 1.11 ± 0.44 .603
C-reactive protein, mg/L 6.83 ± 1.86 20.42 ± 41.14 .001
a Biochemical assays were completed for 84 subjects, among them 52 survivors and 32 non-survivors
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variables analyzed in the study. P values <0.05 were
considered statistically significant.
Results
Hypertension (defined as systolic blood pressure
≥140 mmHg or diastolic blood pressure ≥90 mm or
use of any antihypertensive drug) was present in 87 %
of study subjects. A majority of subjects suffered from
dementia (73 %), heart failure (65 %), and osteoarthritis
(64 %). Sixty-three percent of subjects used at least one
antihypertensive drug (among them beta blockers
14.0 %, ACEIs 29.1 %, ARBs 3.49 %, calcium blockers
12.8 %, spironolactone 15.1 %, thiazides 3.49 %,
thiazide-like diuretics 8.14 %, loop diuretics 22.1 %),
aspirin 23.3 %, GPIIb/IIIa inhibitors 3.49 %, statins
3.49%, nitrates 18.6 %, insulin 2.33%, oral antidiabetic
drugs 6.98 %, and nonsteroidal anti-inflammatory drugs
8.14 %.
Out of the 86 study participants, 52 (60 %) sur-
vived 360 days or more. Survivors compared to non-
survivors were more likely to have hypertension;
higher mean MMSE scores; higher serum albumin
levels; and lower mean serum levels of CRP, IL-6,
and ET-1 (Tables 1 and 2). The Mann–Whitney U test
did not reveal significant differences between survi-
vors and non-survivors regarding body mass index,
blood pressure, and functional measures. In the
univariate Cox proportional hazards model, improved
centenarian survival was associated with a higher
MMSE, Barthel Index, and serum albumin concentra-
tion. In addition, centenarian longevity was associated
with a lower white blood cell (WBC) count as well as
lower serum CRP, IL-6, and ET-1 concentrations
(Table 3). We also found that centenarian survival
was inversely correlated with IL-6 after adjustment
for WBC, CRP, TNF-α, and ET-1 (hazard ratio,
HR = 1.211, 95 % confidence interval (CI) 1.005–
1.459; P < .044) and for ET-1 after adjustment for
WBC, CRP, TNF-α, and IL-6 (HR = 4.412, 95 % CI
1.019–19.105; P < .047). Individuals with MMSE ≥13
points had higher 360-day survival probability
(P < .001) as did subjects with Katz ADL ≥1 point
(P < .001), Barthel Index ≥15 points (P < .001), and
Lawton IADL ≥10 points (P = .009) (Fig. 1). Higher
probability of 360-day survival was also observed with
WBC levels lower than 8.3 g/L (P = .039), CRP
serum concentrations lower than 10 mg/L (P = .001),
IL-6 lower than 6 pg/mL, and ET-1 lower than 1.1 pg/
mL (Fig. 2). Centenarians, when compared with
quinquagenarians, had higher concentrations of vascu-
lar activation markers (sP-selectin, sICAM-1,
sVCAM-1), inflammatory markers (IL-6 and TNF-α),
MMP-1, TIMP-1, and MMP-9 and lower sCD40-L
and PAI-1 concentrations (Table 2). Spearman’s rank
correlation analysis revealed a dependency between
functional measures and certain biochemical markers
Table 2 Selected biochemical markers in the centenarian group (n = 43) and the quinquagenarian control group (n = 30)













Age, years 101.1 ± 1.0 100.9 ± 0.7 101.4 ± 1.3 .457 51.8 ± 5.0 <.001
sP-selectin, ng/mL 77.9 ± 86.5 84.0 ± 102.7 67.9 ± 49.9 .497 35.7 ± 17.4 <.001
sICAM-1, ng/mL 258 ± 114 257 ± 83 261 ± 154 .652 166 ± 77 <.001
sVCAM-1, ng/mL 689 ± 251 660 ± 218 737 ± 296 .373 428 ± 109 <.001
sCD40-L, pg/mL 795 ± 2330 906 ± 2880 672 ± 1110 .246 1690 ± 4649 .010
IL-6, pg/mL 5.92 ± 3.41 4.84 ± 3.41 7.87 ± 2.47 .003 1.03 ± 0.65 <.001
ET-1, pg/mL 1.03 ± 0.32 0.95 ± 0.29 1.19 ± 0.33 .005 0.92 ± 0.34 .150
TNF-α, pg/mL 4.13 ± 6.09 3.44 ± 4.65 5.39 ± 8.11 .407 1.00 ± 0.31 <.001
PAI-1, ng/mL 15.5 ± 5.0 19.4 ± 61.8 8.1 ± 5.9 .949 37.6 ± 72.4 .006
MMP-1, ng/mL 12.7 ± 49.5 15.7 ± 61.0 6.9 ± 1.3 .532 1.9 ± 49.6 <.001
TIMP-1, ng/mL 504 ± 166 485 ± 177 540 ± 141 .198 183 ± 74 <.001
MMP-9, ng/mL 1192 ± 762 1164 ± 737 1246 ± 830 .769 159 ± 96 <.001
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(Table 4). ET-1 correlated neither with systolic nor
with diastolic blood pressure or any marker of
inflammation.
Discussion
We conducted a multidimensional analysis of health
status in a representative group of centenarians, includ-
ing clinical, functional, and biochemical measures with
respect to 360-day survival. We also determined cyto-
k ine leve l s in a con t ro l g roup of hea l thy
quinquagenarians. Centenarians who survived 360 days,
as compared with non-survivors, did not demonstrate
significant differences in terms of initial clinical mea-
sures. These measures include significant medical con-
ditions, current pharmacological treatment, functional
status (aside from significant MMSE variation), and
physical examination findings. Minimal variation in lab-
oratory data was observed in our study group, with the
exception of albumin which is a recognized predictor of
survival in elderly patients (McMurtry and Rosenthal
1995; D’Erasmo et al. 1997) and CRP which is a risk
factor for cardiovascular disease (Tracy et al. 1997;
Buckley et al. 2009) (Table 1). Although blood pressure
was not significantly higher in subjects who survived
360 days, hypertension was more common in the survi-
vor group. Some differences that had been significant
with regard to 180-day survival, e.g., systolic blood
pressure, mean arterial pressure, basic and instrumental
activities of daily living measures, creatinine, cystatin C,
or folate serum levels (Szewieczek et al. 2015), lost their
significance with respect to 360-day survival. However,
Cox proportional hazards regression model (in univari-
ate analyses) and Kaplan–Meier survival analysis com-
bined with the Wilcoxon–Gehan statistic nonetheless
suggest a predictive value not only of MMSE but also
measures of independence in basic and instrumental
activities of daily living (Katz ADL, Barthel Index, and
Lawton IADL for 360-day survival) (Fig. 1, Table 3).
Functional measures as a predictor of centenarian lon-
gevity is in agreement with results observed by others
(Mossakowska et al. 2014). We found that among func-
tional measures, MMSE scores are particularly potent
predictors of survival in elderly populations (Park et al.
2013; Santabárbara et al. 2014) including centenarians
(Mossakowska et al. 2014) and suggest that cognitive
function reflects global health status in centenarians.
We examined endogenous factors to show an associ-
ation, if any, with current functional status and longevity
among centenarians. Our results revealed increased
levels of inflammatory markers and/or vascular function
markers including adhesion molecules, markers of ex-
tracellular matrix metabolism, and arterial stiffness
(with the exception of sCD40-L, ET-1, and PAI-1) in
c e n t e n a r i a n s a s c omp a r e d w i t h h e a l t h y
quinquagenarians (Table 2). We found also multiple
correlations between these molecules (Table 4). These
results confirmed the existence of low-grade systemic
inflammation in our centenarian study group, in line
with centenarian studies found in the literature
(Franceschi et al. 2007). Richter et al. (2003) reported
Table 3 TheCox proportional hazardsmodel univariate survival analysis for functional and biochemical measures (hazard ratio of death per
unit of measure)
Measure Hazard ratio 95 % confidence interval P value
MMSE, pointsa 0.934 0.896–0.975 .002
Katz ADL, pointsa 0.840 0.716–0.985 .032
Barthel Index, pointsa 0.988 0.977–0.999 .026
Albumin, g/Lb 0.926 0.870–0.986 .016
White blood cells, G/Lb 1.161 1.059–1.273 .001
C-reactive protein, mg/Lb 1.032 1.014–1.050 <.001
TNF-αc 1.024 0.960–1.091 .473
IL-6, pg/mLc 1.182 1.047–1.335 .007
ET-1, pg/mLc 3.711 1.233–11.169 .020
aAnalysis of 86 centenarians, among them 52 survivors and 34 non-survivors
b Analysis of 84 centenarians, among them 52 survivors and 32 non-survivors
c Analysis of 43 centenarians, among them 28 survivors and 15 non-survivors
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increased levels of adhesion molecules associated with
age. Surprisingly, our results suggest that centenarians,
compared with quinquagenarians, had lower PAI-1 levels
(Table 2). These results seem to be inconsistent with the
role of PAI-1 as a marker of age-related hypercoagulabil-
ity (Cesari et al. 2010). Higher 360-day survival proba-
bility was associated with lower WBC and lower levels
of CRP, IL-6, and ET-1 (Fig. 2). Finally, we observed
positive correlations between albumin and functional
measures and negative correlations between inflammato-
ry markers and functional measures (Table 4). The asso-
ciation between survival and IL-6 was also significant
after adjustment for WBC, CRP, TNF-α, and ET-1. Of
note, IL-6 correlated negatively with systolic blood pres-
sure (Table 4), while blood pressure was identified as a
factor positively correlated with 180-day survival in cen-
tenarians (Szewieczek et al. 2015). These results indicate
the significant influence of the inflammatory state on
cognitive function and independence in basic and
instrumental activities of daily living. Blüher et al.
(2005) reported on the relationship between CRP and
IL-6 and impaired glucose tolerance, as well as between
IL-6 and obesity, glucose metabolism, and insulin resis-
tance. An association between elevated levels of TNF-α
(but not IL-6) and mortality in a group of 126 centenar-
ians was observed by Bruunsgaard et al. (2003). CRP
was not associated with increased mortality when TNF-α
was included in the analysis. Inconsistent results were
obtained in a large population-based cohort (Wichmann
et al. 2014), where elevated but constant CRP was asso-
ciated with lower risk of cognitive impairment while an
increasing CRP level over a period of 20 years was
associated with increased risk of cognitive impairment
in statin nonusers. In addition, both high IL-6 and its
increase were associated with greater risk of cognitive
impairment. Centenarians who survived 180 days had
lower sVCAM-1 levels as compared with those who
did not survive (Szewieczek et al. 2011). However, the
results of our study suggest that there was no correlation
between centenarian 360-day survival and vascular status
markers sP-selectin, sICAM-1, and sVCAM-1, with the
exception of ET-1. Despite a lack of correlation between
Fig. 1 Kaplan–Meier survival probability of centenarians classi-
fied according to a Mini-Mental State Examination scores ≥13
versus lower values, b Katz Index of Independence in Activities
of Daily Living (ADL) ≥1 versus lower values, c Barthel Index of
Activities of Daily Living (Barthel Index) ≥15 versus lower values,
and d Lawton Instrumental Activities of Daily Living Scale (IADL)
≥10 versus lower values
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360-day survival and vascular status markers, there was a
positive correlation between inflammatory markers and
vascular status makers. These vascular status markers
were markedly higher in centenarians in comparison to
younger individuals. Their concentration depends on
TNF-α and IL-6, but many other factors can also influ-
ence their production (Wojakowski and Gminski 2001;
Blann et al. 2003). High levels of circulating adhesion
molecules are considered independent risk factors for
cardiovascular diseases (Hwang et al. 1997). Simulta-
neous measurement of sICAM-1 and CRP may serve as
a risk marker for future coronary events (Luc et al. 2003).
Among patients with coronary artery disease, soluble
adhesion molecules sVCAM-1 and sICAM-1 are risk
markers for death due to cardiovascular complications
(Blankenberg et al. 2001). Markers of arterial stiffness
and extracellular matrix metabolism (MMP-1, MMP-9,
and TIMP-1) were also markedly higher in centenarians
as compared with quinquagenarians, indicating higher
cardiovascular risk (Bizbiz et al. 1996). MMP-9 and
TIMP-1 were found to be related to all-cause mortality
risk in elderly patients (Hansson et al. 2011). Soluble
CD40L is another marker of immunological activity.
CD40 and CD40 ligand (CD40L) have a critical role in
the pathophysiology of atherosclerosis and atherothrom-
bosis (Yuan et al. 2010). We observed lower sCD40L
levels in centenarians as compared to quinquagenarians
(Table 2). However, sCD40L levels correlated positively
with sVCAM-1, MMP-1, and PAI-1. Our earlier paper
revealed higher sCD40L levels in centenarians who sur-
vived 180 days as compared with non-survivors
(Szewieczek et al. 2011) (Table 2). Our results seem to
be inconsistent with results observed in other studies. In
geriatric study groups, higher sCD40L levels were ob-
served than in younger study groups, although geriatric
patient groups under the age of 80 years had higher
sCD40L levels than geriatric patient groups over the
age of 80 in the same study (Inami et al. 2009). Baldus
et al. (2003) observed an association between sCD40L
and increased cardiac risk in patients with acute coronary
syndromes in the CAPTURE trial. Soluble CD40L is
considered a risk marker both for cardiovascular disease
Fig. 2 Kaplan–Meier survival probability of centenarians classi-
fied according to awhite blood cells <8.3 G/L versus higher values,
b C-reactive protein concentration <10 mg/L versus higher values,
c interleukin-6 concentration <6 pg/mL versus higher values, and d
endothelin-1 concentration <1.1 pg/mL versus higher values
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and adverse events, especially in patients with acute
coronary disease (Tousoulis et al. 2010). An association
between increased levels of sCD40L and metabolic syn-
drome in prediabetic patients, hypertension, and elevated
cholesterol concentration has been reported (Genc et al.
2012). However, in TACTICS-TIMI 18, sCD40L was
not associated with an increased risk of ischemic events
in non-ST elevation acute coronary syndromes when
patients were treated with platelet GPIIb/IIIa inhibitors
(Morrow et al. 2008). Similarly, no association between
sCD40L and cardiovascular outcomes in a large cohort of
patients with acute coronary syndrome in OPUS TIMI-
16 trial was found (Olenchock et al. 2008). Thus, the role
of sCD40L as a cardiovascular risk marker needs further
evaluation. A novel finding of our study was identifica-
tion of potent vasoconstrictor ET-1 as a negative survival
risk marker in centenarians. ET-1 is involved in the
pathogenesis of hypertension, atherosclerosis, and chron-
ic heart failure (Brunner et al. 2006). It has been revealed
that ET-1 exerts proinflammatory activity (Elisa et al.
Table 4 Correlations between
blood pressure, functional mea-
sures, and biochemical markers in
centenarians (n = 43)
Functional measure Biochemical marker Spearman’s rank
correlation coefficient
P value
Systolic blood pressure ET-1 −0.031 .845
IL-6 −0.371 .014
PAI −0.325 .034
Diastolic blood pressure ET-1 −0.060 .702
PAI −0.345 .023
MMSE Albumin 0.592 <.001
CRP −0.316 .041
TNF-α −0.318 .038
Katz ADL Albumin 0.559 <.001
CRP −0.389 .011
IL-6 −0.410 .006




Lawton IADL Albumin 0.473 .001




IL-6 CRP 0.406 .006
TNF-α 0.390 .008
sP-selectin MMP-1 0.359 .018
MMP-9 0.560 <.001
sICAM-1 sVCAM-1 0.476 .001
PAI-1 0.305 .047
sVCAM-1 sICAM-1 0.476 .001
TIMP-1 0.313 .041
sCD40-L 0.374 .015
sCD40-L sVCAM-1 0.374 .015
PAI-1 0.687 <.001
MMP-1 0.326 .035
TIMP-1 MMP-9 0.387 .010
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2015). We found a distinct association between ET-1
levels and mortality in centenarians. ET-1 levels of
1.1 pg/mL ormorewere associatedwith a 54% reduction
in 360-day survival probability (Fig. 2). The relationship
between ET-1 and 360-day survival was still significant
after adjustment for WBC, CRP, TNF-α, and IL-6. ET-1
was already identified as a strong independent predictor
of increased mortality in elderly patients with severe
congestive heart failure (Selvais et al. 2000; Van Beneden
et al. 2004). However, our observation might be surpris-
ing because we had previously identified mildly elevated
blood pressure to be a factor associated with higher 180-
day survival probability in the same group of centenar-
ians (Szewieczek et al. 2015). In other studies, ET-1
correlated positively with systolic blood pressure in sep-
tuagenarians treated for hypertension (Skalska et al.
2009). In our study, ET-1 correlated neither with blood
pressure in centenarians (Table 4) nor with any inflam-
matory markers that might suggest that the vasoconstric-
tive action of this molecule can be diminished with very
advanced age.
Amajor limitation of our study was the relatively low
number of subjects of whom only half had performed all
biochemical tests, which may influence statistical
analysis.
In summary, our results indicate that the phenomenon
described as inflammaging not only exists in centenar-
ians but also influences their performance and survival.
Functional measures, especially MMSE, and in-
flammatory markers as well as some vascular
function molecules can be considered prognostic
survival factors; among them, IL-6 and ET-1 re-
vealed the most potent significance as independent
survival risk markers in centenarians. For centenar-
ians, the prognostic role of traditional metabolic
indices like glucose, cholesterol, and creatinine
levels are significantly limited.
Conclusion
Functional level is associatedwith an inflammatory state
in centenarians; functional measures, inflammatory
markers, and endothelin-1 are predictors of 360-day
survival in centenarians.
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